Search

everythinglearnresearchcommunity

for

Search:↓

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Vitamin D3 and its analogues affect skin cell growth and development depending on cell density, calcium levels, and serum presence.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Venlafaxine can cause hair loss, which stops after discontinuation.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Vitamin A toxicity can cause serious health issues like hypercalcemia and is often overlooked.

Vitamin B12 deficiency can rarely cause excessive daytime sleepiness.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

TGF-β2 plays a key role in human hair growth and development.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Taking biotin supplements can cause incorrect thyroid test results, leading to wrong diagnoses.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.